Ping An Biomedical Co., Ltd. (NASDAQ: PASW) Stock Competitors & Peer Comparison
See PASW's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Apparel - Manufacturers Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for PASW and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| PASW | $0.13 | -0.53% | 2.4M | -1.20 | -$0.11 | N/A |
| RL | $388.92 | +0.39% | 23.7B | 22.33 | $17.40 | +0.96% |
| LEVI | $22.55 | +0.58% | 8.8B | 15.56 | $1.45 | +2.57% |
| GIL | $56.72 | -0.54% | 8.7B | 16.88 | $3.36 | +1.67% |
| VFC | $14.87 | +0.88% | 5.8B | 26.57 | $0.56 | +2.44% |
| KTB | $84.90 | +1.02% | 4.7B | 14.32 | $5.93 | +2.48% |
| PVH | $82.47 | +0.99% | 3.8B | 7.37 | $11.18 | +0.18% |
| ZGN | $13.76 | -1.08% | 3.7B | 28.66 | $0.48 | +0.99% |
| COLM | $57.42 | -0.64% | 2.9B | 15.95 | $3.60 | +2.10% |
| FIGS | $14.69 | -1.01% | 2.5B | 66.77 | $0.22 | N/A |
Stock Comparison
Ralph Lauren Corporation (NYSE: RL)
PASW vs RL Comparison August 2026
Ping An Biomedical Co., Ltd. (NASDAQ: PASW) plays a significant role within the Consumer Cyclical sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PASW stands at 2.4M. In comparison, RL has a market cap of 23.7B. Regarding current trading prices, PASW is priced at $0.13 on the NASDAQ, while RL trades at $388.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PASW currently has a P/E ratio of -1.20, whereas RL's P/E ratio is 22.33. In terms of profitability, PASW's ROE is -0.67%, compared to RL's ROE of +0.36%. Regarding short-term risk, PASW is more volatile compared to RL. This indicates higher risk in terms of short-term price fluctuations for PASW.Check RL's competition here
Levi Strauss & Co. (NYSE: LEVI)
PASW vs LEVI Comparison August 2026
Ping An Biomedical Co., Ltd. (NASDAQ: PASW) plays a significant role within the Consumer Cyclical sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PASW stands at 2.4M. In comparison, LEVI has a market cap of 8.8B. Regarding current trading prices, PASW is priced at $0.13 on the NASDAQ, while LEVI trades at $22.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PASW currently has a P/E ratio of -1.20, whereas LEVI's P/E ratio is 15.56. In terms of profitability, PASW's ROE is -0.67%, compared to LEVI's ROE of +0.29%. Regarding short-term risk, PASW is more volatile compared to LEVI. This indicates higher risk in terms of short-term price fluctuations for PASW.Check LEVI's competition here
Gildan Activewear Inc. (NYSE: GIL)
PASW vs GIL Comparison August 2026
Ping An Biomedical Co., Ltd. (NASDAQ: PASW) plays a significant role within the Consumer Cyclical sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PASW stands at 2.4M. In comparison, GIL has a market cap of 8.7B. Regarding current trading prices, PASW is priced at $0.13 on the NASDAQ, while GIL trades at $56.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PASW currently has a P/E ratio of -1.20, whereas GIL's P/E ratio is 16.88. In terms of profitability, PASW's ROE is -0.67%, compared to GIL's ROE of +0.02%. Regarding short-term risk, PASW is more volatile compared to GIL. This indicates higher risk in terms of short-term price fluctuations for PASW.Check GIL's competition here
V.F. Corporation (NYSE: VFC)
PASW vs VFC Comparison August 2026
Ping An Biomedical Co., Ltd. (NASDAQ: PASW) plays a significant role within the Consumer Cyclical sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PASW stands at 2.4M. In comparison, VFC has a market cap of 5.8B. Regarding current trading prices, PASW is priced at $0.13 on the NASDAQ, while VFC trades at $14.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PASW currently has a P/E ratio of -1.20, whereas VFC's P/E ratio is 26.57. In terms of profitability, PASW's ROE is -0.67%, compared to VFC's ROE of +0.16%. Regarding short-term risk, PASW is more volatile compared to VFC. This indicates higher risk in terms of short-term price fluctuations for PASW.Check VFC's competition here
Kontoor Brands, Inc. (NYSE: KTB)
PASW vs KTB Comparison August 2026
Ping An Biomedical Co., Ltd. (NASDAQ: PASW) plays a significant role within the Consumer Cyclical sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PASW stands at 2.4M. In comparison, KTB has a market cap of 4.7B. Regarding current trading prices, PASW is priced at $0.13 on the NASDAQ, while KTB trades at $84.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PASW currently has a P/E ratio of -1.20, whereas KTB's P/E ratio is 14.32. In terms of profitability, PASW's ROE is -0.67%, compared to KTB's ROE of +0.46%. Regarding short-term risk, PASW is more volatile compared to KTB. This indicates higher risk in terms of short-term price fluctuations for PASW.Check KTB's competition here
PVH Corp. (NYSE: PVH)
PASW vs PVH Comparison August 2026
Ping An Biomedical Co., Ltd. (NASDAQ: PASW) plays a significant role within the Consumer Cyclical sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PASW stands at 2.4M. In comparison, PVH has a market cap of 3.8B. Regarding current trading prices, PASW is priced at $0.13 on the NASDAQ, while PVH trades at $82.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PASW currently has a P/E ratio of -1.20, whereas PVH's P/E ratio is 7.37. In terms of profitability, PASW's ROE is -0.67%, compared to PVH's ROE of +0.03%. Regarding short-term risk, PASW is more volatile compared to PVH. This indicates higher risk in terms of short-term price fluctuations for PASW.Check PVH's competition here
Ermenegildo Zegna N.V. (NYSE: ZGN)
PASW vs ZGN Comparison August 2026
Ping An Biomedical Co., Ltd. (NASDAQ: PASW) plays a significant role within the Consumer Cyclical sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PASW stands at 2.4M. In comparison, ZGN has a market cap of 3.7B. Regarding current trading prices, PASW is priced at $0.13 on the NASDAQ, while ZGN trades at $13.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PASW currently has a P/E ratio of -1.20, whereas ZGN's P/E ratio is 28.66. In terms of profitability, PASW's ROE is -0.67%, compared to ZGN's ROE of +0.10%. Regarding short-term risk, PASW is less volatile compared to ZGN. This indicates lower risk in terms of short-term price fluctuations for PASW.Check ZGN's competition here
Columbia Sportswear Company (NASDAQ: COLM)
PASW vs COLM Comparison August 2026
Ping An Biomedical Co., Ltd. (NASDAQ: PASW) plays a significant role within the Consumer Cyclical sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PASW stands at 2.4M. In comparison, COLM has a market cap of 2.9B. Regarding current trading prices, PASW is priced at $0.13 on the NASDAQ, while COLM trades at $57.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PASW currently has a P/E ratio of -1.20, whereas COLM's P/E ratio is 15.95. In terms of profitability, PASW's ROE is -0.67%, compared to COLM's ROE of +0.13%. Regarding short-term risk, PASW is more volatile compared to COLM. This indicates higher risk in terms of short-term price fluctuations for PASW.Check COLM's competition here
FIGS, Inc. (NYSE: FIGS)
PASW vs FIGS Comparison August 2026
Ping An Biomedical Co., Ltd. (NASDAQ: PASW) plays a significant role within the Consumer Cyclical sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PASW stands at 2.4M. In comparison, FIGS has a market cap of 2.5B. Regarding current trading prices, PASW is priced at $0.13 on the NASDAQ, while FIGS trades at $14.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PASW currently has a P/E ratio of -1.20, whereas FIGS's P/E ratio is 66.77. In terms of profitability, PASW's ROE is -0.67%, compared to FIGS's ROE of +0.14%. Regarding short-term risk, PASW is more volatile compared to FIGS. This indicates higher risk in terms of short-term price fluctuations for PASW.Check FIGS's competition here
Hanesbrands Inc. (NYSE: HBI)
PASW vs HBI Comparison August 2026
Ping An Biomedical Co., Ltd. (NASDAQ: PASW) plays a significant role within the Consumer Cyclical sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PASW stands at 2.4M. In comparison, HBI has a market cap of 2.3B. Regarding current trading prices, PASW is priced at $0.13 on the NASDAQ, while HBI trades at $6.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PASW currently has a P/E ratio of -1.20, whereas HBI's P/E ratio is 5.53. In terms of profitability, PASW's ROE is -0.67%, compared to HBI's ROE of +1.57%. Regarding short-term risk, PASW is less volatile compared to HBI. This indicates lower risk in terms of short-term price fluctuations for PASW.Check HBI's competition here
Under Armour, Inc. (NYSE: UAA)
PASW vs UAA Comparison August 2026
Ping An Biomedical Co., Ltd. (NASDAQ: PASW) plays a significant role within the Consumer Cyclical sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PASW stands at 2.4M. In comparison, UAA has a market cap of 2.3B. Regarding current trading prices, PASW is priced at $0.13 on the NASDAQ, while UAA trades at $5.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PASW currently has a P/E ratio of -1.20, whereas UAA's P/E ratio is 44.67. In terms of profitability, PASW's ROE is -0.67%, compared to UAA's ROE of -0.32%. Regarding short-term risk, PASW is more volatile compared to UAA. This indicates higher risk in terms of short-term price fluctuations for PASW.Check UAA's competition here
Under Armour, Inc. (NYSE: UA)
PASW vs UA Comparison August 2026
Ping An Biomedical Co., Ltd. (NASDAQ: PASW) plays a significant role within the Consumer Cyclical sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PASW stands at 2.4M. In comparison, UA has a market cap of 2.2B. Regarding current trading prices, PASW is priced at $0.13 on the NASDAQ, while UA trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PASW currently has a P/E ratio of -1.20, whereas UA's P/E ratio is 43.71. In terms of profitability, PASW's ROE is -0.67%, compared to UA's ROE of -0.32%. Regarding short-term risk, PASW is more volatile compared to UA. This indicates higher risk in terms of short-term price fluctuations for PASW.Check UA's competition here
G-III Apparel Group, Ltd. (NASDAQ: GIII)
PASW vs GIII Comparison August 2026
Ping An Biomedical Co., Ltd. (NASDAQ: PASW) plays a significant role within the Consumer Cyclical sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PASW stands at 2.4M. In comparison, GIII has a market cap of 1.4B. Regarding current trading prices, PASW is priced at $0.13 on the NASDAQ, while GIII trades at $33.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PASW currently has a P/E ratio of -1.20, whereas GIII's P/E ratio is 15.13. In terms of profitability, PASW's ROE is -0.67%, compared to GIII's ROE of +0.07%. Regarding short-term risk, PASW is more volatile compared to GIII. This indicates higher risk in terms of short-term price fluctuations for PASW.Check GIII's competition here
Canada Goose Holdings Inc. (NYSE: GOOS)
PASW vs GOOS Comparison August 2026
Ping An Biomedical Co., Ltd. (NASDAQ: PASW) plays a significant role within the Consumer Cyclical sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PASW stands at 2.4M. In comparison, GOOS has a market cap of 849.6M. Regarding current trading prices, PASW is priced at $0.13 on the NASDAQ, while GOOS trades at $8.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PASW currently has a P/E ratio of -1.20, whereas GOOS's P/E ratio is 16.19. In terms of profitability, PASW's ROE is -0.67%, compared to GOOS's ROE of +0.10%. Regarding short-term risk, PASW is more volatile compared to GOOS. This indicates higher risk in terms of short-term price fluctuations for PASW.Check GOOS's competition here
Oxford Industries, Inc. (NYSE: OXM)
PASW vs OXM Comparison August 2026
Ping An Biomedical Co., Ltd. (NASDAQ: PASW) plays a significant role within the Consumer Cyclical sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PASW stands at 2.4M. In comparison, OXM has a market cap of 542M. Regarding current trading prices, PASW is priced at $0.13 on the NASDAQ, while OXM trades at $36.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PASW currently has a P/E ratio of -1.20, whereas OXM's P/E ratio is 22.13. In terms of profitability, PASW's ROE is -0.67%, compared to OXM's ROE of -0.07%. Regarding short-term risk, PASW is more volatile compared to OXM. This indicates higher risk in terms of short-term price fluctuations for PASW.Check OXM's competition here
Superior Group of Companies, Inc. (NASDAQ: SGC)
PASW vs SGC Comparison August 2026
Ping An Biomedical Co., Ltd. (NASDAQ: PASW) plays a significant role within the Consumer Cyclical sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PASW stands at 2.4M. In comparison, SGC has a market cap of 203.7M. Regarding current trading prices, PASW is priced at $0.13 on the NASDAQ, while SGC trades at $13.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PASW currently has a P/E ratio of -1.20, whereas SGC's P/E ratio is 19.16. In terms of profitability, PASW's ROE is -0.67%, compared to SGC's ROE of +0.04%. Regarding short-term risk, PASW is more volatile compared to SGC. This indicates higher risk in terms of short-term price fluctuations for PASW.Check SGC's competition here
Vince Holding Corp. (NASDAQ: VNCE)
PASW vs VNCE Comparison August 2026
Ping An Biomedical Co., Ltd. (NASDAQ: PASW) plays a significant role within the Consumer Cyclical sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PASW stands at 2.4M. In comparison, VNCE has a market cap of 82.1M. Regarding current trading prices, PASW is priced at $0.13 on the NASDAQ, while VNCE trades at $6.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PASW currently has a P/E ratio of -1.20, whereas VNCE's P/E ratio is 10.48. In terms of profitability, PASW's ROE is -0.67%, compared to VNCE's ROE of +0.18%. Regarding short-term risk, PASW is less volatile compared to VNCE. This indicates lower risk in terms of short-term price fluctuations for PASW.Check VNCE's competition here
Fuxing China Group Limited (NASDAQ: FFFZ)
PASW vs FFFZ Comparison August 2026
Ping An Biomedical Co., Ltd. (NASDAQ: PASW) plays a significant role within the Consumer Cyclical sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PASW stands at 2.4M. In comparison, FFFZ has a market cap of 68.8M. Regarding current trading prices, PASW is priced at $0.13 on the NASDAQ, while FFFZ trades at $4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PASW currently has a P/E ratio of -1.20, whereas FFFZ's P/E ratio is N/A. In terms of profitability, PASW's ROE is -0.67%, compared to FFFZ's ROE of N/A. Regarding short-term risk, PASW is more volatile compared to FFFZ. This indicates higher risk in terms of short-term price fluctuations for PASW.Check FFFZ's competition here
Jerash Holdings (US), Inc. (NASDAQ: JRSH)
PASW vs JRSH Comparison August 2026
Ping An Biomedical Co., Ltd. (NASDAQ: PASW) plays a significant role within the Consumer Cyclical sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PASW stands at 2.4M. In comparison, JRSH has a market cap of 67.3M. Regarding current trading prices, PASW is priced at $0.13 on the NASDAQ, while JRSH trades at $5.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PASW currently has a P/E ratio of -1.20, whereas JRSH's P/E ratio is 18.93. In terms of profitability, PASW's ROE is -0.67%, compared to JRSH's ROE of +0.08%. Regarding short-term risk, PASW is less volatile compared to JRSH. This indicates lower risk in terms of short-term price fluctuations for PASW.Check JRSH's competition here
Culp, Inc. (NASDAQ: CULP)
PASW vs CULP Comparison August 2026
Ping An Biomedical Co., Ltd. (NASDAQ: PASW) plays a significant role within the Consumer Cyclical sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PASW stands at 2.4M. In comparison, CULP has a market cap of 43.2M. Regarding current trading prices, PASW is priced at $0.13 on the NASDAQ, while CULP trades at $3.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PASW currently has a P/E ratio of -1.20, whereas CULP's P/E ratio is -4.74. In terms of profitability, PASW's ROE is -0.67%, compared to CULP's ROE of -0.14%. Regarding short-term risk, PASW is less volatile compared to CULP. This indicates lower risk in terms of short-term price fluctuations for PASW.Check CULP's competition here
Brillia Inc (AMEX: BRIA)
PASW vs BRIA Comparison August 2026
Ping An Biomedical Co., Ltd. (NASDAQ: PASW) plays a significant role within the Consumer Cyclical sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PASW stands at 2.4M. In comparison, BRIA has a market cap of 33.4M. Regarding current trading prices, PASW is priced at $0.13 on the NASDAQ, while BRIA trades at $1.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PASW currently has a P/E ratio of -1.20, whereas BRIA's P/E ratio is 16.69. In terms of profitability, PASW's ROE is -0.67%, compared to BRIA's ROE of -0.00%. Regarding short-term risk, PASW is less volatile compared to BRIA. This indicates lower risk in terms of short-term price fluctuations for PASW.Check BRIA's competition here
J-Long Group Limited (NASDAQ: JL)
PASW vs JL Comparison August 2026
Ping An Biomedical Co., Ltd. (NASDAQ: PASW) plays a significant role within the Consumer Cyclical sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PASW stands at 2.4M. In comparison, JL has a market cap of 17.3M. Regarding current trading prices, PASW is priced at $0.13 on the NASDAQ, while JL trades at $4.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PASW currently has a P/E ratio of -1.20, whereas JL's P/E ratio is 6.76. In terms of profitability, PASW's ROE is -0.67%, compared to JL's ROE of +0.17%. Regarding short-term risk, PASW is less volatile compared to JL. This indicates lower risk in terms of short-term price fluctuations for PASW.Check JL's competition here
JX Luxventure Limited (NASDAQ: LLL)
PASW vs LLL Comparison August 2026
Ping An Biomedical Co., Ltd. (NASDAQ: PASW) plays a significant role within the Consumer Cyclical sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PASW stands at 2.4M. In comparison, LLL has a market cap of 10.8M. Regarding current trading prices, PASW is priced at $0.13 on the NASDAQ, while LLL trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PASW currently has a P/E ratio of -1.20, whereas LLL's P/E ratio is -0.10. In terms of profitability, PASW's ROE is -0.67%, compared to LLL's ROE of N/A. Regarding short-term risk, PASW is less volatile compared to LLL. This indicates lower risk in terms of short-term price fluctuations for PASW.Check LLL's competition here
Neo-Concept International Group Holdings Limited (NASDAQ: NCI)
PASW vs NCI Comparison August 2026
Ping An Biomedical Co., Ltd. (NASDAQ: PASW) plays a significant role within the Consumer Cyclical sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PASW stands at 2.4M. In comparison, NCI has a market cap of 6.2M. Regarding current trading prices, PASW is priced at $0.13 on the NASDAQ, while NCI trades at $12.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PASW currently has a P/E ratio of -1.20, whereas NCI's P/E ratio is 152.63. In terms of profitability, PASW's ROE is -0.67%, compared to NCI's ROE of -0.01%. Regarding short-term risk, PASW is more volatile compared to NCI. This indicates higher risk in terms of short-term price fluctuations for PASW.Check NCI's competition here
Perfect Moment Ltd. Common Stock (AMEX: PMNT)
PASW vs PMNT Comparison August 2026
Ping An Biomedical Co., Ltd. (NASDAQ: PASW) plays a significant role within the Consumer Cyclical sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PASW stands at 2.4M. In comparison, PMNT has a market cap of 5.7M. Regarding current trading prices, PASW is priced at $0.13 on the NASDAQ, while PMNT trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PASW currently has a P/E ratio of -1.20, whereas PMNT's P/E ratio is -0.15. In terms of profitability, PASW's ROE is -0.67%, compared to PMNT's ROE of -12.19%. Regarding short-term risk, PASW is less volatile compared to PMNT. This indicates lower risk in terms of short-term price fluctuations for PASW.Check PMNT's competition here
Xcel Brands, Inc. (NASDAQ: XELB)
PASW vs XELB Comparison August 2026
Ping An Biomedical Co., Ltd. (NASDAQ: PASW) plays a significant role within the Consumer Cyclical sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PASW stands at 2.4M. In comparison, XELB has a market cap of 5.6M. Regarding current trading prices, PASW is priced at $0.13 on the NASDAQ, while XELB trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PASW currently has a P/E ratio of -1.20, whereas XELB's P/E ratio is -0.31. In terms of profitability, PASW's ROE is -0.67%, compared to XELB's ROE of -0.95%. Regarding short-term risk, PASW is less volatile compared to XELB. This indicates lower risk in terms of short-term price fluctuations for PASW.Check XELB's competition here
JX Luxventure Limited (NASDAQ: JXJT)
PASW vs JXJT Comparison August 2026
Ping An Biomedical Co., Ltd. (NASDAQ: PASW) plays a significant role within the Consumer Cyclical sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PASW stands at 2.4M. In comparison, JXJT has a market cap of 4.9M. Regarding current trading prices, PASW is priced at $0.13 on the NASDAQ, while JXJT trades at $0.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PASW currently has a P/E ratio of -1.20, whereas JXJT's P/E ratio is 1.47. In terms of profitability, PASW's ROE is -0.67%, compared to JXJT's ROE of +0.22%. Regarding short-term risk, PASW is less volatile compared to JXJT. This indicates lower risk in terms of short-term price fluctuations for PASW.Check JXJT's competition here
Delta Apparel, Inc. (AMEX: DLA)
PASW vs DLA Comparison August 2026
Ping An Biomedical Co., Ltd. (NASDAQ: PASW) plays a significant role within the Consumer Cyclical sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PASW stands at 2.4M. In comparison, DLA has a market cap of 4.1M. Regarding current trading prices, PASW is priced at $0.13 on the NASDAQ, while DLA trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PASW currently has a P/E ratio of -1.20, whereas DLA's P/E ratio is -0.06. In terms of profitability, PASW's ROE is -0.67%, compared to DLA's ROE of -0.20%. Regarding short-term risk, PASW is less volatile compared to DLA. This indicates lower risk in terms of short-term price fluctuations for PASW.Check DLA's competition here
Sequential Brands Group, Inc. (NASDAQ: SQBG)
PASW vs SQBG Comparison August 2026
Ping An Biomedical Co., Ltd. (NASDAQ: PASW) plays a significant role within the Consumer Cyclical sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PASW stands at 2.4M. In comparison, SQBG has a market cap of 0. Regarding current trading prices, PASW is priced at $0.13 on the NASDAQ, while SQBG trades at $6.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PASW currently has a P/E ratio of -1.20, whereas SQBG's P/E ratio is N/A. In terms of profitability, PASW's ROE is -0.67%, compared to SQBG's ROE of -1.42%. Regarding short-term risk, PASW is less volatile compared to SQBG. This indicates lower risk in terms of short-term price fluctuations for PASW.Check SQBG's competition here
Perry Ellis International, Inc. (NASDAQ: PERY)
PASW vs PERY Comparison August 2026
Ping An Biomedical Co., Ltd. (NASDAQ: PASW) plays a significant role within the Consumer Cyclical sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PASW stands at 2.4M. In comparison, PERY has a market cap of 0. Regarding current trading prices, PASW is priced at $0.13 on the NASDAQ, while PERY trades at $27.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PASW currently has a P/E ratio of -1.20, whereas PERY's P/E ratio is 50.00. In terms of profitability, PASW's ROE is -0.67%, compared to PERY's ROE of +0.15%. Regarding short-term risk, PASW is more volatile compared to PERY. This indicates higher risk in terms of short-term price fluctuations for PASW.Check PERY's competition here
Ever-Glory International Group, Inc. (NASDAQ: EVK)
PASW vs EVK Comparison August 2026
Ping An Biomedical Co., Ltd. (NASDAQ: PASW) plays a significant role within the Consumer Cyclical sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PASW stands at 2.4M. In comparison, EVK has a market cap of 0. Regarding current trading prices, PASW is priced at $0.13 on the NASDAQ, while EVK trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PASW currently has a P/E ratio of -1.20, whereas EVK's P/E ratio is N/A. In terms of profitability, PASW's ROE is -0.67%, compared to EVK's ROE of -0.00%. Regarding short-term risk, PASW is less volatile compared to EVK. This indicates lower risk in terms of short-term price fluctuations for PASW.Check EVK's competition here
JX Luxventure Limited (NASDAQ: KBSF)
PASW vs KBSF Comparison August 2026
Ping An Biomedical Co., Ltd. (NASDAQ: PASW) plays a significant role within the Consumer Cyclical sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PASW stands at 2.4M. In comparison, KBSF has a market cap of 0. Regarding current trading prices, PASW is priced at $0.13 on the NASDAQ, while KBSF trades at $3.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PASW currently has a P/E ratio of -1.20, whereas KBSF's P/E ratio is -1.46. In terms of profitability, PASW's ROE is -0.67%, compared to KBSF's ROE of -0.10%. Regarding short-term risk, PASW is less volatile compared to KBSF. This indicates lower risk in terms of short-term price fluctuations for PASW.Check KBSF's competition here